相关实验视频
Updated: Sep 13, 2025

04:56
Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
109
早期的密集治疗,以预防分支动脉瘤性疾病的神经系统恶化
Yen-Chu Huang1, Hsu-Huei Weng2, Yuan-Hsiung Tsai2
1Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Chang-Gung University College of Medicine, No. 6 West Chia-Pu Road, Putz City, Chiayi County 613, Taiwan.
Therapeutic advances in neurological disorders
|July 29, 2025
概括
早期强化治疗,包括双抗血小板治疗 (DAPT) 和高强度他类药物,可显著降低分支动脉瘤性疾病 (BAD) 患者的早期神经系统恶化 (END). 这种方法可以改善恢复,而不会增加安全风险.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 临床试验 临床试验
背景情况:
- 枝状动脉瘤性疾病 (BAD) 是一种中风亚型,与早期神经系统恶化 (END) 和患者的不良结果有关.
- 尽管与大动脉动脉样硬化有相似之处,但BAD的最佳治疗策略仍未确定.
研究的目的:
- 评估早期双抗血小板治疗 (DAPT) 与高强度他类药物结合的疗效和安全性.
- 为了确定这种密集治疗是否减少了END,并改善了BAD患者的结果.
主要方法:
- 一个前性,单臂研究与历史对照 (NCT04824911).
- 患者在症状出现后24小时内接受了阿司匹林,皮多格雷尔和高强度他类药物.
- 结果与接受标准抗血小板治疗和低强度他类药物的历史队列相比.
主要成果:
- 主要终点 (END或复发性中风) 在密集治疗中较少发生 (34.1%对48.1%).
- 强化治疗在7天内显著减少了END,并在90天后改善了功能结果.
- 两组之间在复发性中风率,严重出血或死亡率方面没有发现显著差异.
结论:
- 用DAPT和高强度他类药物的早期密集治疗有效地减少了END,并改善了BAD的恢复.
- 这种治疗方法似乎是安全的,没有增加严重出血或死亡率.
- 建议进行进一步的研究,以在更大的前性研究中验证这些发现.
相关概念视频
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Atherosclerosis IV: Nursing Management
51
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
51
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Atherosclerosis I: Introduction
87
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
87
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
40
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40
Coronary Artery Disease V: Interprofessional Care
33
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
33

